Particle Works continues to pave the way for particle perfection with the highly anticipated launch of its second revolutionary platform, the Automated Library Synthesis (ALiS) System.

Lonza has launched an innovative new capsule solution for intestinal (enteric) drug delivery.

At Lab Innovations 2022, Ellutia will present the newest addition to its nitrosamine detection solutions, the Automated Total Nitrosamine Analyser (ATNA).

NDA Group announces expansion of NDA Advisory Board with the appointment of Sigrid Klaar.

Paradigm4’s REVEAL Integrative Analytics platform enables Alnylam Pharmaceuticals to discover novel, genetically-validated drug targets from population scale biobank genotype-phenotype datasets and underlies the extraordinary pace and productivity of Alnylam’s RNAi therapeutics pipeline.

Ubiquigent Limited today announced the appointment of Dr. Sheelagh Frame, Chief Scientific Officer, to the Company’s Board of Directors.

Thermo Fisher Scientific Inc. has introduced the Thermo Scientific Glacios 2 Cryo-Transmission Electron Microscope, a powerful microscope with new automation and high-resolution imaging capabilities.

A Welsh MedTech company is taking the next steps towards launching its unique technology, after securing a partnership with a medical devices company.

Optibrium has announced three key appointments: Michelle Harrison as head of strategic marketing, Chris Khoury as associate director of business development, and Imran Ghauri as business development manager.

Qnovia, Inc., a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement therapy and cardiopulmonary diseases, has announced it has raised $17 million in Series A funding.